Yahoo!
Webinar Description
Cannabis ranks as the second most commonly used substance nationwide, trailing only tobacco and alcohol (NIH). Approximately 16 million Americans report regular cannabis use (NIH), with the majority initiating use during their teenage years (NIH). The broad legalization of marijuana has brought about challenges, with a failure to address increased toxicity and adverse effects on early teens and young adults. Notably, there has been a marked rise in cannabis-related hospitalizations for anxiety, paranoia, and psychosis, causing significant concern.
Research indicates that cannabis use accelerates the onset of schizophrenia by three years. Furthermore, a worrisome association exists between cannabis and various psychotic disorders, including schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, delusional disorder, and substance-induced psychotic disorder. Cannabis is also linked to the onset of bipolar disorder with psychotic features and an increase in the manifestation of manic symptoms.
Like this webinar? Click here to view packages that contain this webinar.
Qualifications:
Learning Objectives:
- Discussing the trends and increase in cannabis use amongst adolescents and young adults.
- Education on the difference between traditional cannabis and high concentrate THC oil.
- Understanding the impact of chronic cannabis use on anxiety, depressive disorders, and reduction of social and occupational functioning.
- Comprehend the correlation of cannabis use related to early-onset psychosis and initial psychotic breaks.
- Implementation of interventions of cannabis use disorder and how to treat it.
Agenda:
1. Introduction (5 minutes)
- Welcome and Introduction to the Speaker
- Brief Overview of Presentation Topics
2. History of Cannabis Policy and Legalization (20 minutes)
- Overview of Historical Cannabis Policies in the United States
- Milestones in the Legalization Movement
- Current Status of Cannabis Legalization Nationwide
3. Cannabis Products and THC Levels (25 minutes)
- Types of Cannabis Products: Flower, Edibles, Concentrates, etc.
- Understanding THC (Tetrahydrocannabinol) and CBD (Cannabidiol), Delta 8 & 10
- Impact of THC Levels on Users
4. Cannabis-Induced Psychosis (45 minutes)
- Definition and Characteristics of Cannabis-Induced Psychosis
- Statistics and Trends
- Recognizing Symptoms and Early Warning Signs
5. Other Mental Health Issues Impacted by Cannabis (15 minutes)
- Impact on Anxiety and Paranoia
- Association with Mood Disorders
- Link to bipolar disorder and mania
7. Interventions for Cannabis Use Disorder (30 minutes)
- Treatment Approaches: Behavioral Therapies
- Pharmacological Interventions and legal interventions
- Support and Resources for Individuals and Families
9. Case Studies and Practical Applications (15 minutes)
- Real-life examples of cannabis-related mental health issues
- Strategies for Intervention and Support
10. Prevention Strategies and Education (10 minutes)
- Evidence based prevention strategies
- Implementing Preventive Measures
11. Conclusion and Summary (5 minutes)
- Recap of Key Takeaways
- Thanking the Audience for Participation
8. Q&A Session (10 minutes)
- Open the floor for questions and discussion
Total Presentation Time: 3 hours
Certificates Provider - This Webinar Offers 3 Continuing Education Credits
This webinar is recorded and will not grant live credits.
- CE You! is an approved sponsor of the Maryland Board of Social Work Examiners for continuing education credits for licensed social workers in Maryland.
CE You! maintains responsibility for this program.
This presentation is open to:
- Behavior Analysts
- Social Workers
- Professional Counselors
- Therapists
- Psychologists
- Licensed Mental Health Practitioners
- Medical Doctors and Other Health Professionals
- Other professionals interacting with populations engaged in mental health based services
This online class is offered at an advanced level ,and is beneficial for an advanced level clinician:
- New practitioners who wish to gain enhanced insight surrounding the topic
- Experienced practitioners who seek to increase and expand fundamental knowledge surrounding the subject matter
- Advanced practitioners seeking to review concepts and reinforce practice skills and/or access additional consultation
- Managers seeking to broaden micro and/or macro perspectives
Official information
- Refunds: Registrants who are unable to attend a Thrapy Express seminar or live webinars may ask for, and will receive, a credit or refund (your choice). Refund requests will be processed within 3 business days. When an attendee knows in advance that they are unable to attend we ask that they inform Thrapy Express ahead of time by emailing [email protected] or by calling or texting (631) 202-1010 this allows us to free up the spot in the training in the event that a training is at or near capacity.
- Disability Access: If you require ADA accommodations, please contact our office 30 days or more before the event. We cannot ensure accommodations without adequate prior notification.
- Please Note: Licensing Boards change regulations often, and while we attempt to stay abreast of their most recent changes, if you have questions or concerns about this course meeting your specific board’s approval, we recommend you contact your board directly to obtain a ruling.
- The grievance policy for trainings provided by the NEFESH INTERNATIONAL is available here
- Satisfactory Completion: Participants must have paid the tuition fee, logged in and out each day, attended the entire webinar, and completed an evaluation to receive a certificate (If this is a pre-recorded program, a post-test with a passing grade of 80% to receive a certificate.) Failure to log in or out will result in forfeiture of credit for the entire course. No exceptions will be made. Partial credit is not available. Certificates are available after satisfactory course completion by clicking here
- Participants will receive their certificate electronically upon completion of the webinar and course evaluation form.
- There is no conflict of interest or commercial support for this program.